Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Working Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.261.351.592.521.69

What is the latest Working Capital/Sales ratio of CONCORD BIOTECH ?

The latest Working Capital/Sales ratio of CONCORD BIOTECH is 1.26 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.26
Mar20241.35
Mar20231.59
Mar20222.52
Mar20211.69

How is Working Capital/Sales of CONCORD BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 1.26
-6.67
Mar2024 1.35
-15.09
Mar2023 1.59
-36.90
Mar2022 2.52
49.11
Mar2021 1.69 -

Other Financial Ratios of CONCORD BIOTECH


Compare Working Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,939.0 Cr -2.8% -2.2% -30.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-2.8%

-2.2%

-30.2%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses